调节生物可用性的因素:在各组之间比较血液中含量的关键考虑因素
Ana Cirovic1, Aleksandar Cirovic1
1Institute of Anatomy, Faculty of Medicine, University of Belgrade, Dr Subotica 4/2, Belgrade, 11000, Serbia.
概括
暴露于会给健康带来风险,但个人的敏感性各不相同. 营养缺乏,肺功能和肝脏健康等因素显著影响体内的水平.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 人类健康风险评估
背景情况:
- (Cd) 是一种有毒的重金属,对健康构成重大风险.
- 暴露与癌症,心血管疾病,脏疾病和骨质疏松症有关.
- 对Cd相关疾病的个体风险并不统一.
研究的目的:
- 审查影响血中 (Cd) 水平的因素.
- 提供Cd吸收和分布的全面分析.
- 突出影响不同人群Cd水平的变量.
主要方法:
- 对暴露和健康结果研究的文献综述.
- 对影响肠道吸收的因素的分析.
- 检查改变循环的条件.
主要成果:
- 营养素缺乏 (铁,,),贫血,慢性肺炎和副甲状腺激素 (PTH) 低可以增加Cd的吸收.
- 慢性肝脏疾病可以提高循环中的Cd水平.
- 年龄,性别,酒精和伴随性疾病显著影响测量Cd血液水平.
结论:
- 了解影响Cd血液水平的因素对于准确的风险评估至关重要.
- 个人Cd水平的变化需要考虑多种生理和生活方式因素.
- 进一步的研究应该将这些变量纳入全面的CD健康影响研究.
相关概念视频
Factors Affecting Drug Biotransformation: Biological
915
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
915
Bioavailability: Influencing Factors
679
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
679
Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229


